Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000005

CFO AND TREASURER sold 21,000 shares at an average $452.07 ($9,493,483)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $146.03 $3,066,630 29,118 D
2025-11-10 Sale : show line 2 in the form 10b5-1 −1,052 $446.51 $469,727 28,066 D
2025-11-10 Sale : show line 3 in the form 10b5-1 −1,539 $447.47 $688,655 26,527 D
2025-11-10 Sale : show line 4 in the form 10b5-1 −3,356 $448.33 $1,504,595 23,171 D
2025-11-10 Sale : show line 5 in the form 10b5-1 −653 $449.00 $293,197 22,518 D
2025-11-10 Sale : show line 6 in the form 10b5-1 −600 $450.80 $270,480 21,918 D
2025-11-10 Sale : show line 7 in the form 10b5-1 −1,065 $451.87 $481,240 20,853 D
2025-11-10 Sale : show line 8 in the form 10b5-1 −2,170 $452.76 $982,479 18,683 D
Open-market sales · 21,000 sh · avg $452.07 · $9,493,483

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-10 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option −21,000 $146.03 2027-03-15 21,000 10,312 D
Loading xslF345X05/primarydocument.xml…